-
January 26, 2021 Important Correction for MindMed Trials (Plus Changes In MMED/MMEDF’S Timelines)What's up Psychedelic Investors? In today's episode entitled :Important Correction for MindMed Trials (Plus Changes...
-
January 24, 2021 More MindMed Catalysts: MMED MMEDF Stock Opportunity (Plus Jr & Kevin O’Leary comments)Today we'll discuss More MindMed Catalysts: MMED MMEDF Stock Opportunity (Plus Jr & Kevin O'Leary...
-
January 22, 2021 Psychedelic Business News Spotlight: January 22, 2021This week in psychedelic industry news: the first psychedelic stock index, new products, mergers, and...
-
January 22, 2021 Daniel Carcillo’s Wesana Health Raises $4 Million to Expand Psychedelic ResearchWesana Health, founded by former NHL star Daniel Carcillo, has raised $4 million to continue...
-
January 21, 2021 MindMed Stock Catalysts for 2021: NASDAQ, Clinical Trial Results and More (MMED / MMEDF)In today's episode, we discuss :MindMed Stock Catalysts for 2021: NASDAQ, Clinical Trial Results and...
-
January 18, 2021 Is MindMed Expanding to PSILOCYBIN? (BIG MMED / MMEDF Stock NEWS)In today’s episode, we will be covering some Massive MindMed news that broke on January...
-
January 16, 2021 MindMed Expands MICRODOSING trials (BIG MMED/MMEDF stock UPDATE)In today's episode "MindMed Expands Microdosing Trials", we'll discuss a Big MindMed Stock Update. On...
-
January 15, 2021 Psychedelic Business News Spotlight: January 15, 2021This week in psychedelic business news, IPOs, employee stock options, mergers, research, and more.
-
January 14, 2021 Why Psychedelic Stocks are NOT Cannabis 2.0 (Huge MindMed Stock Opportunity)In today’s episode, we will be discussing why Psychedelic Stocks, like MindMed (MMED / MMEDF)...
-
January 10, 2021 Is Compass Pathways a GOOD INVESTMENT? (CMPS stock analysis)In this episode, we take a deep dive into Compass Pathways (CMPS), a psychedelic-medicines company...
